Association between the molecular pathobiology of essential hypertension and thrombotic diseases
- PMID: 10880368
- PMCID: PMC1850190
- DOI: 10.1016/S0002-9440(10)64509-9
Association between the molecular pathobiology of essential hypertension and thrombotic diseases
Comment on
-
Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.Am J Pathol. 2000 Jul;157(1):111-22. doi: 10.1016/S0002-9440(10)64523-3. Am J Pathol. 2000. PMID: 10880382 Free PMC article.
References
-
- Dzau VJ: Angiotensin-converting enzyme as a multimechanistic factor in CAD. J Myocard Ischemia 1995, 7(suppl 1):6-14
-
- Morishita R, Gibbons GH, Tomita N, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function. Arterioscler Thromb Vasc Biol 2000, 20:915-922 - PubMed
-
- Rossi GP, Sacchetto A, Rizzoni D, Bova S, Porteri E, Mazzocchi G, Belloni AS, Bahcelioglu M, Nussdorfer GG, Pessina AC: Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms. Arterioscler Thromb Vasc Biol 2000, 20:949-956 - PubMed
-
- Edgington TS, Mackman N, Brand K, Ruf W: The structural biology of expression and function of tissue factor. Thromb Haemost 1991, 66:67-79 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
